29/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
28/05/2025
|
12:00
|
GSK stops Phase 3 trial on cUTIs for efficacy
|
RNS
|
28/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
27/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/05/2025
|
12:16
|
positive CHMP opinion on Blenrep in EU
|
RNS
|
23/05/2025
|
07:00
|
FDA approves Nucala COPD indication
|
RNS
|
23/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
21/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
20/05/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
20/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
19/05/2025
|
07:00
|
Blenrep for 2L+ multiple myeloma approved in Japan
|
RNS
|
19/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
16/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
15/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
14/05/2025
|
07:00
|
GSK to acquire efimosfermin
|
RNS
|
14/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
13/05/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
13/05/2025
|
12:56
|
Update on belrestotug development programme
|
RNS
|
13/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
12/05/2025
|
15:31
|
Block listing Interim Review
|
RNS
|
12/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
09/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
08/05/2025
|
17:15
|
Director/PDMR Shareholding
|
RNS
|
08/05/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
08/05/2025
|
11:15
|
Linerixibat GLISTEN pIII trial data at EASL
|
RNS
|
08/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
07/05/2025
|
18:22
|
Result of AGM
|
RNS
|
07/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
06/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
02/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
01/05/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
01/05/2025
|
15:00
|
Total Voting Rights
|
RNS
|
01/05/2025
|
07:00
|
Nucala MATINEE data in COPD published in NEJM
|
RNS
|
01/05/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
30/04/2025
|
07:05
|
Transaction in Own Shares
|
RNS
|
30/04/2025
|
07:00
|
1st Quarter Results
|
RNS
|
29/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
28/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
25/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
24/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
23/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
22/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
17/04/2025
|
16:13
|
Blenrep licensed by UK MHRA
|
RNS
|
17/04/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|
17/04/2025
|
07:10
|
Arexvy now ACIP recommended for 50-59 at risk
|
RNS
|
17/04/2025
|
07:05
|
GSK 5-in-1 meningitis vaccine recommended in US
|
RNS
|
17/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
16/04/2025
|
07:00
|
Transaction in Own Shares
|
RNS
|
15/04/2025
|
15:30
|
Director/PDMR Shareholding
|
RNS
|